...
首页> 外文期刊>Haematologica >Sweet's syndrome in a patient with idiopathic myelofibrosis and thymoma-myasthenia gravis-immunodeficiency complex: efficacy of treatment with etretinate | Haematologica
【24h】

Sweet's syndrome in a patient with idiopathic myelofibrosis and thymoma-myasthenia gravis-immunodeficiency complex: efficacy of treatment with etretinate | Haematologica

机译:特发性骨髓纤维化和胸腺瘤-重症肌无力-免疫缺陷综合症患者的Sweet's综合征血液学

获取原文
           

摘要

Here we present the case of a patient affected with a unique association of Sweet's syndrome, idiopathic myelofibrosis, spindle-cell thymoma, myasthenia gravis and Good's syndrome (a rare form of thymoma-related, combined immunodeficiency presenting with recurrent respiratory infections). Conventional therapies (corticosteroids, colchicine, DDS, clofazimine) were ineffective or were contraindicated. Treatment with etretinate (50 mg/day) proved effective on skin lesions. Moreover, the patient's general condition unexpectedly improved, with long-lasting (11 months) suppression of respiratory infections and a slight but consistent improvement of hematological parameters such as Hct, MCV, Hb level, RBC, WBC and lymphocyte absolute counts.
机译:在这里,我们介绍一例患上Sweet氏综合症,特发性骨髓纤维化,纺锤状细胞胸腺瘤,重症肌无力和Good氏综合症(与胸腺瘤相关的罕见形式,伴有反复呼吸道感染的综合免疫缺陷)的独特患者。常规疗法(皮质类固醇,秋水仙碱,DDS,氯法齐明)无效或禁忌。事实证明,使用维甲酸(50 mg /天)治疗对皮肤病变有效。此外,患者的总体状况出乎意料地得到了改善,可以持久(11个月)抑制呼吸道感染,血液学指标(如Hct,MCV,Hb水平,RBC,WBC和淋巴细胞绝对计数)略微但持续改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号